Go to the article
- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News & Insights
In the News
July 18, 2025 - Source: PharmaVoice
Lisa Dwyer, Robert Hudock, Amanda Klingler, Christina Markus, Geneviève Michaux, Brian Miller, Lauren Roth and Adam Solander's Client Alert is referenced in a profile discussing the FDA publishing 200 complete response letters sent to pharma companies for drugs that were later approved
Featured Lawyers
Lisa M. Dwyer
Washington, D.C.
Robert J. Hudock
Washington, D.C.
Amanda J. Klingler
Washington, D.C.
Christina M. Markus (Chris)
Washington, D.C.
Geneviève Michaux
Brussels
Brian P. Miller
Miami
Close
Featured Lawyers
Lisa M. Dwyer
Washington, D.C.
Robert J. Hudock
Washington, D.C.
Amanda J. Klingler
Washington, D.C.
Christina M. Markus (Chris)
Washington, D.C.
Geneviève Michaux
Brussels
Brian P. Miller
Miami
Lauren K. Roth
Washington, D.C.
Adam C. Solander
Washington, D.C.